Cellular and Molecular Mechanisms of Prion Disease
Standard
Cellular and Molecular Mechanisms of Prion Disease. / Sigurdson, Christina J; Bartz, Jason C; Glatzel, Markus.
in: ANNU REV PATHOL-MECH, Jahrgang 14, 24.01.2019, S. 497-516.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Cellular and Molecular Mechanisms of Prion Disease
AU - Sigurdson, Christina J
AU - Bartz, Jason C
AU - Glatzel, Markus
PY - 2019/1/24
Y1 - 2019/1/24
N2 - Prion diseases are rapidly progressive, incurable neurodegenerative disorders caused by misfolded, aggregated proteins known as prions, which are uniquely infectious. Remarkably, these infectious proteins have been responsible for widespread disease epidemics, including kuru in humans, bovine spongiform encephalopathy in cattle, and chronic wasting disease in cervids, the latter of which has spread across North America and recently appeared in Norway and Finland. The hallmark histopathological features include widespread spongiform encephalopathy, neuronal loss, gliosis, and deposits of variably sized aggregated prion protein, ranging from small, soluble oligomers to long, thin, unbranched fibrils, depending on the disease. Here, we explore recent advances in prion disease research, from the function of the cellular prion protein to the dysfunction triggering neurotoxicity, as well as mechanisms underlying prion spread between cells. We also highlight key findings that have revealed new therapeutic targets and consider unanswered questions for future research.
AB - Prion diseases are rapidly progressive, incurable neurodegenerative disorders caused by misfolded, aggregated proteins known as prions, which are uniquely infectious. Remarkably, these infectious proteins have been responsible for widespread disease epidemics, including kuru in humans, bovine spongiform encephalopathy in cattle, and chronic wasting disease in cervids, the latter of which has spread across North America and recently appeared in Norway and Finland. The hallmark histopathological features include widespread spongiform encephalopathy, neuronal loss, gliosis, and deposits of variably sized aggregated prion protein, ranging from small, soluble oligomers to long, thin, unbranched fibrils, depending on the disease. Here, we explore recent advances in prion disease research, from the function of the cellular prion protein to the dysfunction triggering neurotoxicity, as well as mechanisms underlying prion spread between cells. We also highlight key findings that have revealed new therapeutic targets and consider unanswered questions for future research.
KW - Journal Article
KW - Neurodegenerative Diseases
KW - Animals
KW - Prion Diseases/etiology
KW - Cattle
KW - Humans
KW - Prion Proteins/metabolism
KW - Amyloid
KW - Deer
U2 - 10.1146/annurev-pathmechdis-012418-013109
DO - 10.1146/annurev-pathmechdis-012418-013109
M3 - SCORING: Review article
C2 - 30355150
VL - 14
SP - 497
EP - 516
JO - ANNU REV PATHOL-MECH
JF - ANNU REV PATHOL-MECH
SN - 1553-4006
ER -